Methylphenidate Capsule, Extended Release
Product Images NDC 0781-2385

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Methylphenidate (NDC 0781-2385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mglabel (10mglabel)

Methylphenidate HCl Extended-Release Capsules 10 mg label showing a 100-capsule bottle from Sandoz Inc. The label includes dosage form, strength, storage instructions, and manufacturing information. The product is indicated as prescription only with a note to dispense with a medication guide.*

FDA Label Image

20mglabel (20mglabel)

Label for Methylphenidate HCl Extended-Release Capsules 20 mg, oral extended-release capsules by Sandoz Inc. The label indicates the product contains 100 capsules and includes storage instructions and manufacturer information. The product is for prescription use only.*

FDA Label Image

30mglabel (30mglabel)

Label of Methylphenidate HCl Extended-Release Capsules 30 mg by Sandoz Inc. The label includes dosage strength, quantity of 100 capsules, and storage instructions. It states the product is prescription-only, and the capsules are extended-release. The manufacturer is Sandoz Inc., with additional information on the container and dosing guidance.*

FDA Label Image

40mglabel (40mglabel)

Label for Methylphenidate HCl Extended-Release Capsules 40 mg by Sandoz Inc. The label states 'Rx Only' and indicates a package of 100 capsules. It includes storage instructions and notes that each capsule contains methylphenidate hydrochloride 40 mg. The label also mentions dispensing with a Medication Guide and provides manufacturer information for Sandoz Inc.*

FDA Label Image

Fig1 (Fig1)

A line graph depicting mean d-methylphenidate plasma levels (ng/mL) over time (hours) comparing methylphenidate hydrochloride extended-release capsules 40 mg once daily and methylphenidate hydrochloride tablets 20 mg twice daily. The graph shows plasma concentration changes for both formulations up to 24 hours.*

FDA Label Image

Fig2 (Fig2)

A bar graph comparing the mean final scores minus mean baseline scores for Methylphenidate Hydrochloride Extended-release Capsules versus Placebo. The Methylphenidate group shows a negative mean change, while the Placebo group shows a positive mean change. Error bars represent the standard error of the mean. Sample sizes are 63 for Methylphenidate and 71 for Placebo.*

FDA Label Image

Ritalin La Structural Formula. (Ritalin La 01)

Chemical structure of methylphenidate hydrochloride, showing the core aromatic ring and piperidine ring with attached functional groups, including an ester (COOCH3) and hydrochloride salt (HCl).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.